MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) saw a significant decrease in short interest in the month of December. As of December 15th, there was short interest totaling 62,429 shares, a decrease of 44.0% from the November 30th total of 111,394 shares. Based on an average daily volume of 166,101 shares, the short-interest ratio is currently 0.4 days. Based on an average daily volume of 166,101 shares, the short-interest ratio is currently 0.4 days.
MediPharm Labs Trading Down 1.6%
Shares of MEDIF stock opened at $0.05 on Friday. MediPharm Labs has a fifty-two week low of $0.04 and a fifty-two week high of $0.09. The business’s 50 day moving average price is $0.05 and its 200-day moving average price is $0.05.
MediPharm Labs Company Profile
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Recommended Stories
- Five stocks we like better than MediPharm Labs
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
